Neuralink, the brain-computer interface (BCI) venture founded by Elon Musk, is now working on implants designed to help people with blindness regain vision. During a recent discussion with startup accelerator Y Combinator, Musk shared new insights into Neuralink’s developments, including its next ambitious step: direct stimulation of the visual cortex.
Musk explained that the company is preparing for its first vision-related human implants within the next six to twelve months. The goal is to write directly into the brain’s visual cortex, potentially allowing even those who are completely blind to experience visual input. While not restoring biological eyesight, the chip would simulate vision by stimulating the brain’s visual processing center.
He revealed that one of Neuralink’s test monkeys has had the visual implant for three years already, and although the resolution may be low at first, future versions could reach high-definition levels and even perceive ultraviolet or infrared light creating experiences beyond human norm.
Neuralink made headlines in 2021 with its “Monkey MindPong” demo, in which a monkey controlled a video game with its thoughts. Since then, the company has secured FDA approval for human trials and aims to use its chip to aid those with paralysis by enabling thought-based control of computers and robotic systems.
The broader BCI field is rapidly growing. Apple has partnered with Synchron and Nvidia to explore thought-based control within its ecosystem. Other companies like Paradromics and Precision Neuroscience are also progressing, with recent milestones such as first human implants and regulatory clearances.
What gives Neuralink a unique edge is its synergy with Musk’s other ventures. Technologies from Tesla, SpaceX, and xAI could integrate with Neuralink’s systems such as Tesla’s Optimus robot or xAI’s advancements in deep learning to create a connected ecosystem where users can act with mere thought.
Despite the excitement, safety and precision remain critical. Brain implant procedures are highly complex, and ensuring reliable outcomes is essential for the technology’s long-term success. If done right, this innovation could redefine the future of human-machine interaction and healthcare.
Powered by Markelitics.com
